+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ampio Pharmaceuticals Inc - logo

Ampio Pharmaceuticals is a biopharmaceutical company that focuses on developing therapies for the treatment of prevalent inflammatory conditions in the United States. Ampio has received over 180 patents throughout the world, with hundreds more pending. The company's leading product candidates are Ampion and Optina. Amption is a intra-articular injection being studied for the treatment of osteoarthritis of the knee. Optina is an oral agent being studied for the treatment of diabetic macular edema. Ampio is headquartered in Englewood, Colorado.

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • September 2021
  • 1013 Pages
From
From
From
From
Osteoarthritis Pain - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 233 Pages
From
Calcitonin Gene Related Peptide - Pipeline Review, H2 2020 - Product Thumbnail Image

Calcitonin Gene Related Peptide - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 96 Pages
From
From
From
From
Osteoarthritis - Pipeline Insight, 2021 - Product Thumbnail Image

Osteoarthritis - Pipeline Insight, 2021

  • Clinical Trials
  • July 2021
  • 60 Pages
From
Knee osteoarthritis - Pipeline Insight, 2022 - Product Thumbnail Image

Knee osteoarthritis - Pipeline Insight, 2022

  • Drug Pipelines
  • March 2022
  • 100 Pages
From
Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020 - Product Thumbnail Image

Aryl Hydrocarbon Receptor - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 122 Pages
From
Loading Indicator